Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Endocrinol. 2014 Apr 29;222(1):87–97. doi: 10.1530/JOE-13-0610

Table 1.

Human Preadipocytes: Donor characteristics

Gender (15) 3M/12F
Age (15) 41 ± 2.5 years
Body mass index (15) 51 ± 3.7 kg/m2
Concomitant diseases (9)
 diabetes 2
 degenerative joint disease 3
 obesity hypoventilation syndrome 3
 gastroesophageal reflux disease 2
 sleep apnea 2
 other*
Medications
 diabetes 2a
 heart/blood pressure 5b
 heartburn 5c
 depression 4d
 inflammation/pain 3e
 other#

Numbers in parentheses on the left indicate the number of donors for which information was available.

Numbers for specific diseases and medications on the right indicate the number of donors. Some donors will have more than one.

*

1 each hypothyroidism, hyperlipidemia, asthma, hypertension, recurrent sinus infection

#

1 each Carbidopa/Levodopa, Unithroid, Ortho Novum, Intraconozole

a

Avandia, Metformin, Prandin

b

Sotalol, Lasix, Digoxin, Avapro, hydrochlorothiazide, Lovenox, Lipitor, Lopid, Verdapamil, Norvasc

c

Prilosec

d

Paxil, Zoloft, Celexa, Trazadone, Prozac, Lorazepam

e

Flonase, Vioxx, Nasalcort, Zyrtec, Vicodin